Non sedating antipsychotic
Patients with reduced renal function Flupentixol has not been studied in renal impairment.
Increased cerebral sensitivity to antipsychotics has been noted in severe renal impairment (see section 4.4).
Other patients may be adequately maintained on dosages of 20-40 mg flupentixol decanoate every 2-4 weeks.
Blood dyscrasias, including thrombocytopenia, have been reported rarely.
Depixol Injection: 20 mg/ml flupentixol decanoate in thin vegetable oil. Injection: 100 mg/ml flupentixol decanoate in thin vegetable oil.
For the full list of excipients, see section 6.1 Adults The usual dosage of flupentixol decanoate lies between 50 mg every 4 weeks and 300 mg every 2 weeks, but some patients may require up to 400 mg weekly. For example, 800 mg ever 2 weeks should not be given.
Depixol should be initiated at low doses orally to check for tolerability before switching to the depot formulation.
Route of administration Deep intramuscular injection into the upper outer buttock or lateral thigh.
Search for non sedating antipsychotic:
More concentrated solutions of flupentixol decanoate (Depixol Conc Injection or Depixol Low Volume Injection) should be used if doses greater than 3 ml (60 mg) are required.